Industrial M&A » By The Online Investor Staff, updated Fri., Apr. 26, 12:11 AM
Recent mergers and acquisitions in the Industrial M&A category.
| This Slide: #2 of 100 |
Slide #2. Balchem Corporation — SensoryEffects
Acquirer:
Balchem Corporation (NASDAQ:BCPC)
Acquiree:
SensoryEffects
Details:
Highlander Partners, L.P., a Dallas-based investment firm, announces the sale of its portfolio company, SensoryEffects, to Balchem Corporation (NASDAQ: BCPC), a publicly-traded human and animal health and wellness company. The purchase price was $567 million, before working capital and other adjustments. The sale represents the culmination of eight years of collaboration and enterprise building between Highlander Partners and SensoryEffects' founder, Chairman and CEO, Charles A. Nicolais, and the management team he assembled. The investment has been the most successful one in Highlander Partners' history and the firm is grateful to Mr. Nicolais and his team for all their efforts and proud of Highlander Partners' substantial role in partnering with him to build a company that is a clear industry leader and poised to thrive for years to come.
Balchem is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Co. has three segments: Human Nutrition and Health, which provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from Co.'s microencapsulation and chelation technologies in addition to basic choline chloride; and Specialty Products, which distributes ethylene oxide, propylene oxide and ammonia.
BCPC SEC Filing Email Alerts Service
Open the BCPC Page at The Online Investor »
|
|||||||||||||||||||||
Open the BCPC Page at The Online Investor (in a new window) »
 Free BCPC Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 97th percentile
(ranked higher than approx. 97% of all stocks covered)
Analysts' Target Price: BCPC Stock Forecast Based on Zacks ABR data; powered by Xignite |
